CD36 and diabetes mellitus: To investigate the priming effect of PPARδ in patients with diabetes and assess the involvement of CD36 in MTB complications, an ex vivo analysis was performed using monocytic cells isolated from both healthy individuals without diabetes and from patients with diabetes.